Sales Force Effectiveness USA 2010

eyeforpharma17-18 May 2010, Princeton, NJ, USA.
SFE USA is a premier conference for pharma. Learn how to develop a winning sales strategy from pharma leaders. 10 Industry VPs will deliver sessions on healthcare reform, customer-centric models, and CRM tools.

SFE USA Program

Pharma In 2010 And Beyond

  • Lean, Mean, Switching machines- What is the future of Sales Force Effectiveness?
    Tony Fross, Senior Director WBB Business Excellence Group, Pfizer
  • Mergers & Acquisitions: What does the future hold?
    Richard Skelly, Senior Director Commercial Evaluations, AstraZeneca
  • Emerging Markets: Building BRIC(s) and Blocs
    Charlotte Sibley, Senior Vice President CBS Business Management, Shire
  • The future of pharma rests on the impending Health Care bill – be prepared and understand the implications
    Pharma Vice President confirmed, Genentech

Sales Excellence

  • Achieve more with less: Which commercial model will be most successful for your company?
    Barry Duke, Vice President Sales, Genzyme
  • Insights into Taro's commercial model strategies
    Joe Malta, Vice President Sales & Marketing, Taro Pharmaceuticals
  • The optimal size of your workforce: How small is big enough?
    Tracy Mills, Senior Director Sales Force Effectiveness, Endo Pharmaceuticals
  • Target managed markets and bring value to these powerful stakeholders
    Don Sawyer, Vice President Commercial Operations, AstraZeneca
  • How to ensure a long-term relationship with your key accounts
    Tony Zecca, Senior Director Sales Strategy, Effectiveness & Innovation, AstraZeneca

Sales Tools And Technology

  • Multi-Channel Management: Integrating promotion effectively across all channels
    Paulash Mohsen, VP Multichannel Marketing, Pfizer
  • Capitalise on the potential of e-detailing to reduce your marketing costs
    John Rotondo, VP & General Manager Commercial Operations, Bayer
  • Case Study: Closed Loop Marketing In A multi-channel environment
    Marc Valdiviezo, Director Marketing Excellence, Sanofi-Aventis
  • What technology should you provide your sales force to achieve optimum sales effectiveness?
    Edson Gemo, Senior Director Business Technology Sales Force Effectiveness Solution Center, Pfizer
    Steve Winawer, Senior Director, US Business Technology, Commercial Operations, Patient & Physician Marketing, Pfizer

Training And Development

  • The Evolution of Physician Behaviour and Implications for New Physician Access Models
    Mark Gleason, Senior Vice President, Corporate Development, Aptilon
  • SUPER PANEL: Scientist Vs salesman: Which approach will enable your sales reps to raise their value to the industry?
    Tim Ryan, Executive Director, Boehringer Ingelheim
    Christine Barczak, East Area Vice Presidnet, GSK
    Todd Lambert, Vice President Sales, Shire,
    Don Hribek, Senior Director of Strategic Accounts, EMD Serono
    Moderator: Greg Neal, Managing Partner, Rx Business Advantage Consulting
  • A sales force to be reckoned with: Transforming Sales Forces with talent upgrades, skills training, and business processes
    Joe Coffey, Vice President Sales, Baxter
  • Case Study: Discover the methodology behind successful training delivery
    Mike Capaldi, AVP Sales Training & Leadership Development, Sanofi-Aventis
  • Value Creation- The Next Frontier for Pharma
    Angela Bakker Lee, Principal, ZS Associates

For further information and registration, please visit:

Most Popular Now

Fasenra (benralizumab) receives US FDA approval fo…

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab)...

A great place to do great things: Developing game-…

Science has spoken: Abbott (NYSE: ABT) is, again, among the best science-based companies to work for in the world. For the 14th year, the journal Science today recognized...

Alzheimer's disease might be a 'whole body' proble…

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scie...

Cancer cells destroyed with dinosaur extinction me…

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international col...

Novartis confirms leadership in multiple sclerosis…

Novartis today announced it will present 54 scientific abstracts from across its multiple sclerosis (MS) research portfolio at the 7th Joint European and Americas Committ...

Amgen and Novartis announce expanded collaboration…

Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Init...

Transplanted hematopoietic stem cells reverse dama…

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mous...

Novartis announces the planned acquisition of Adva…

Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender...

'Precision Medicine' may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the w...

New tissue-engineered blood vessel replacements on…

Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doe...

China's out of control 'silent killer' affects one…

More than one-third of adults in China have high blood pressure - often dubbed the "silent killer" for its lack of symptoms - but only about one in 20 have the condition ...

New US study reveals key reasons why millions of p…

Few of the more than 90 million Americans(1) with obesity are seeking and receiving long-term obesity care, according to new data from the Awareness, Care and Treatment I...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]